CompoAtlas

Pump Fuel Insanity Ballistic Blue Razz

Withdrawn from the US market on 2 April 2024 (according to the DSLD)

PMD Platinum, food supplement from the US market

Label withdrawn from the US market. Pump Fuel Insanity Ballistic Blue Razz (PMD Platinum), a food supplement au code-barres 811020901617, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
PMD Platinum
Barcode
811020901617
Form
Powder
One serving
28 g
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Citric Acid, Malic Acid, Natural and Artificial flavors, Silica, Sucralose, Acesulfame Potassium, FD&C Blue 1 powder Alum Lake, FD&C Blue 1
Ingredient (as written, in English)CategoryPer serving
CaloriesOther55 kcal
Calories from FatOther0 kcal
Total FatFat0 Gram(s)
Saturated FatFat0 Gram(s)
Trans FatFat0 Gram(s)
CholesterolFat0 mg
Total CarbohydratesCarbohydrate14 Gram(s)
Dietary FiberFibre0 Gram(s)
SugarCarbohydrate0 Gram(s)
ProteinProtein0 Gram(s)
Vitamin CVitamin125 mg
Vitamin EVitamin100 UI
CalciumMineral80 mg
PhosphorousMineral40 mg
MagnesiumMineral100 mg
ChromiumMineral50 µg
SodiumMineral40 mg
PotassiumMineral90 mg
PUMP FUEL(R) INSANITY BlendBlend23,815 mg
RAPID ATP(TM) v.3 BlendBlend3,000 mg
CreatineOther substance2,000 mg
Magnesium Creatine ChelateOther substance1,000 mg
AGMA PUMP(TM) BlendBlend2,250 mg
Arginine ComplexBlend2,000 mg
L-ArginineAmino acidnot stated
L-Arginine AKGOther substancenot stated
Di-Arginine Di-MalateAmino acidnot stated
Agmatine ComplexBlend250 mg
Agmatine SulphateOther substancenot stated
L-NorvalineAmino acidnot stated
L-Citrulline L-MalateOther substancenot stated
Beta Burn AgentBlend2,500 mg
CarnoSynAmino acid2,500 mg
AMINO FOCUS BlendBlend1,114 mg
TaurineOther substancenot stated
Caffeine AnhydrousOther substance275 mg
Amla (Phyllanthus emblica) (fruit) extract (Phyllanthus emblica)Plantnot stated
Bitter Orange (Citrus aurantium) (fruit) extract (Citrus aurantium)Plantnot stated
Carnitine TartrateOther substancenot stated
GlutamineAmino acidnot stated
Glutamine AKGOther substancenot stated
Guanidino Propionic AcidOther substancenot stated
IsoleucineAmino acidnot stated
LeucineAmino acidnot stated
N-Acetyl GlutamineOther substancenot stated
Phosphatidyl SerineFatnot stated
ValineAmino acidnot stated
Cinnamon bark extract (Cinnamomum verum)Plantnot stated
TyrosineAmino acidnot stated
VinpocetineOther substancenot stated
GLYCOL LOAD(TM) BlendBlend14,951 mg
MaltodextrinCarbohydratenot stated
Waxy MaizeCarbohydratenot stated
Glycerol powderOthernot stated
Glycine Propionyl L-Carnitine HClOther substancenot stated
Acetyl L-Carnitine Arginate DiHClOther substancenot stated

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Amla (Phyllanthus emblica) (fruit) extract
    Read the warning, when it applies and the studies cited

    Amla - Phyllanthus Emblica

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Applies to products providing more than 3 grams of amla, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Condition of application: Amlapitta, Digestive tonic.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Laxative.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).

    Sources cited by Health Canada (3)
    • CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
    • Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.

    Contraindications

    Condition of application: Laxative.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).

    Sources cited by Health Canada (1)
    • HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html

    Known adverse reactions

    Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.

    When using this product you may experience a laxative effect.

    Health Canada monograph dated 28 March 2025

  • Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

  • Cinnamon bark extract
    Read the warning, when it applies and the studies cited

    Cinnamon - Cinnamomum Verum

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
    • OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé.

    Condition of application: All products except antioxidants.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
    • BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs—Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 26 July 2024

  • Tyrosine
    Read the warning, when it applies and the studies cited

    L-TYROSINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : PMD Platinum

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Pump Fuel Insanity Ballistic Blue Razz : étiquette retirée du marché américain (PMD Platinum): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/811020901617-pump-fuel-insanity-ballistic-blue-razz-pmd-platinum, updated 2 April 2024.

List recorded in 2014. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line